Identification of Penumbra and Infarct in Acute Ischemic Stroke Using Computed Tomography Perfusion-derived Blood Flow and Blood Volume Measurements
Overview
Neurology
Authors
Affiliations
Background And Purpose: We investigated whether computed tomography (CT) perfusion-derived cerebral blood flow (CBF) and cerebral blood volume (CBV) could be used to differentiate between penumbra and infarcted gray matter in a limited, exploratory sample of acute stroke patients.
Methods: Thirty patients underwent a noncontrast CT (NCCT), CT angiography (CTA), and CT perfusion (CTP) scan within 7 hours of stroke onset, NCCT and CTA at 24 hours, and NCCT at 5 to 7 days. Twenty-five patients met the criteria for inclusion and were subsequently divided into 2 groups: those with recanalization at 24 hours (n=16) and those without (n=9). Penumbra was operationally defined as tissue with an admission CBF <25 mL x 100 g(-1) x min(-1) that was not infarcted on the 5- to 7-day NCCT. Logistic regression was applied to differentiate between infarct and penumbra data points.
Results: For recanalized patients, CBF was significantly lower (P<0.05) for infarct (13.3+/-3.75 mL x 100 g(-1) x min(-1)) than penumbra (25.0+/-3.82 mL x 100 g(-1) x min(-1)). CBV in the penumbra (2.15+/-0.43 mL x 100 g(-1)) was significantly higher than contralateral (1.78+/-0.30 mL x 100 g(-1)) and infarcted tissue (1.12+/-0.37 mL x 100 g(-1)). Logistic regression using an interaction term (CBFxCBV) resulted in sensitivity, specificity, and accuracy of 97.0%, 97.2%, and 97.1%, respectively. The interaction term resulted in a significantly better (P<0.05) fit than CBF or CBV alone, suggesting that the CBV threshold for infarction varies with CBF. For patients without recanalization, CBF and CBV for infarcted regions were 15.1+/-5.67 mL x 100 g(-1) x min(-1) and 1.17+/-0.41 mL x 100 g(-1), respectively.
Conclusions: We have shown in a limited sample of patients that CBF and CBV obtained from CTP can be sensitive and specific for infarction and should be investigated further in a prospective trial to assess their utility for differentiating between infarct and penumbra.
Infarct volume as a predictor and therapeutic target in post-stroke cognitive impairment.
Xu L, Shan D, Wu D Front Med (Lausanne). 2025; 12:1519538.
PMID: 39967599 PMC: 11832508. DOI: 10.3389/fmed.2025.1519538.
Lakhani D, Balar A, Ali S, Khan M, Salim H, Koneru M Interv Neuroradiol. 2025; 15910199241308322.
PMID: 39763336 PMC: 11705296. DOI: 10.1177/15910199241308322.
Strinitz M, Zimmer C, Berndt M, Wunderlich S, Boeckh-Behrens T, Maegerlein C BMC Neurol. 2024; 24(1):294.
PMID: 39187761 PMC: 11345997. DOI: 10.1186/s12883-024-03806-w.
Lakhani D, Balar A, Salim H, Koneru M, Wen S, Ozkara B Diagnostics (Basel). 2024; 14(8).
PMID: 38667490 PMC: 11049259. DOI: 10.3390/diagnostics14080845.
Lakhani D, Balar A, Koneru M, Wen S, Ozkara B, Lu H J Clin Med. 2024; 13(6).
PMID: 38541813 PMC: 10971151. DOI: 10.3390/jcm13061588.